基本信息
views: 6
Career Trajectory
Bio
Over the last 30 years, he has been involved in clinical research in chronic lymphocytic leukemia (CLL). During this time the complete remission rate has risen dramatically from approximately 5% to 50 – 60%. This is associated with improvements in developmental therapeutic programs but also a dramatic improvement in the understanding of the biology and prognostic factors of CLL. CLL is a disease of the elderly and the characterization of other cancers in survivors of CLL is vitally important. Understanding of this comparison between incidence and characteristics of other cancers in CLL survivors is vitally important in its own right but must be integrated into clinical understanding of the disease. He is totally committed to providing clinical and intellectual resources at his disposal to support the program.
Research Interests
Papers共 952 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Reginald L. McGee, Jake Reed,Caitlin E. Coombes,Carmen D. Herling,Michael J. Keating,Lynne V. Abruzzo,Kevin R. Coombes
crossref(2024)
CANCERno. 14 (2023): 2192-2200
Philip A. Thompson,Alexandre Bazinet,William G. Wierda,Constantine S. Tam, Susan M. O'Brien, Satabdi Saha,Christine B. Peterson,William Plunkett,Michael J. Keating
Leukemiano. 7 (2023): 1444-1453
Uri Rozovski, Srdana Grgurevic,Carlos Bueso-Ramos,David M. Harris,Ping Li,Zhiming Liu,Ji Yuan Wu,Preetesh Jain,William Wierda,Jan Burger, Susan O'Brien,Nitin Jain,
crossref(2023)
BLOOD (2023)
Ivo Veletic,David M. Harris,Uri Rozovski,Ping Li,Zhiming Liu,Taghi Manshouri, Maria Teresa S. Bertilaccio,George A. Calin, Rares-Constantin Drula,Koichi Takahashi,Ken Furudate,Muharrem Muftuoglu,
BLOOD (2023): 3264
BLOOD (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn